Hadlima (adalimumab-bwwd recalls
The FDA has published 1 recall involving Hadlima (adalimumab-bwwd since 2025. The latest was reported on 5 Nov 2025. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2025
Last 12 months1reported
Class I00% of total
Ongoing1latest 5 Nov 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why hadlima (adalimumab-bwwd is recalled
Companies
By year
Ongoing hadlima (adalimumab-bwwd recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Hadlima (adalimumab-bwwd) injection recalled by Samsung Bioepis Co | Samsung Bioepis | Sterility | NJ |
All hadlima (adalimumab-bwwd recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Hadlima (adalimumab-bwwd) injection recalled by Samsung Bioepis Co | Samsung Bioepis | Sterility | NJ |
Should you stop taking Hadlima (adalimumab-bwwd?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.